Our present findings concerning the potential interactions among LYAR/UBF, LYAR/BRD2-KAT7-JADE3 and/or LYAR/BRD4-KAT7-JADE3 may provide other potential targets for cancer treatment. The gene discussed is LYAR; the disease is cancer.